Clinical Trials Browser

Active not recruiting × Stomach Neoplasms × sintilimab × Clear all

NCT05177068 2025-10-02

Conversion Therapy of Fruquintinib in Combination With Sintilimab and SOX in Unresectable Gastric Cancer

Phase 2 Active not recruiting

Gastrointestinal

Stomach Neoplasms